European Thyroid Journal (Jan 2023)

Real-world application of ATA Guidelines in over 600 aspirated thyroid nodules: is it time to change the size cut-offs for FNA?

  • Stamatina Ioakim,
  • Akheel A Syed,
  • George Zavros,
  • Michalis Picolos,
  • Luca Persani,
  • Angelos Kyriacou

DOI
https://doi.org/10.1530/ETJ-22-0163
Journal volume & issue
Vol. 11, no. 6
pp. 1 – 10

Abstract

Read online

Background: The 2015 American Thyroid Association (ATA) Guidelines recommend the following size cut-offs based on sonographic appearances for subjecting nodules to fine-needle aspiration (FNA) biopsy: low risk: 15 mm and inte rmediate risk and high risk: 10 mm. Objective: We conducted a ‘real-world’ study evaluating the diagnostic performance of the ATA cut-offs against increased thresholds, in the interest of sa fely limiting FNAs. Methods: We performed a retrospective analysis of prospectively collected data on 604 nodules which were sonographically risk-stratified as per th e ATA Guidelines and subsequently subjected to ultrasound-guided FNA. Nodules were c ytologically stratified into ‘benign’ (Bethesda class 2) and ‘non-benign’ (Bethesda cla sses 3–6). We obtained the negative predictive value (NPV), accuracy, FNAs that could be spared, missed ‘non-benign’ cytologies and missed carcinomas on histology, according to the ATA cut-offs compared to higher cut-offs. Results: In low-risk nodules, the high performance of NPV (≈91%) is unaffected by increasing the cut-off to 25 mm, and accuracy improves by 39.4%; 46.8% of FNAs could be spared at the expense of few missed B3–B6 cytologies ( 7.9%) and no missed carcinomas. In intermediate-risk nodules, a 15 mm cut-off increa ses the NPV by 11.3% and accuracy by 40.7%. The spared FNAs approach 50%, while B3–B 6 cytologies are minimal, with no missed carcinomas. In high-risk nodules, low N PV (<35%) and accuracy (<46%) were obtained regardless of cut-off. Moreover, the spared FNAs achieved at higher cut-offs involved numerous missed ‘non-benign’ cytologies and carcinomas. Conclusion: It would be clinically safe to increase the ATA cut-offs for FN A in low-risk nodules to 25 mm and in intermediate-risk nodules to 15 mm.

Keywords